1. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms. (9th November 2020) Authors: Guinart, Daniel; de Filippis, Renato; Rosson, Stella; Patil, Bhagyashree; Prizgint, Lara; Talasazan, Nahal; Meltzer, Herbert; Kane, John M; Gibbons, Robert D Journal: Schizophrenia bulletin Issue: Volume 47:Number 3(2021) Page Start: 644 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS. (1st April 2018) Authors: Maciukiewicz, Malgorzata; Tiwari, Arun; Goncalves, Vanessa; Zai, Clement; Brandl, Eva; Freeman, Natalie; Lieberman, Jeffrey; Meltzer, Herbert; Laughlin, Christopher; Nurmi, Erika; Kennedy, James; Mueller, Daniel Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN. (18th May 2020) Authors: Yoshida, Kazunari; Maciukiewicz, Malgorzata; Marshe, Victoria; Tiwari, Arun; Brandl, Eva; Lieberman, Jeffrey; Meltzer, Herbert; Kennedy, James; Mueller, Daniel Journal: Schizophrenia bulletin Issue: Volume 46(2020)Supplement 1 Page Start: S202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2. (1st April 2018) Authors: Zai, Clement; Tiwari, Arun; Mueller, Daniel; Voineskos, Aristotle; Potkin, Steven G; Lieberman, Jeffrey; Meltzer, Herbert; Remington, Gary; Kennedy, James Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2. (1st April 2018) Authors: Zai, Clement; Tiwari, Arun; Mueller, Daniel; Voineskos, Aristotle; Potkin, Steven G; Lieberman, Jeffrey; Meltzer, Herbert; Remington, Gary; Kennedy, James Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABAA receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia. (November 2018) Authors: Rajagopal, Lakshmi; Huang, Mei; Michael, Eric; Kwon, Sunoh; Meltzer, Herbert Journal: Neuropsychopharmacology Issue: Volume 43:Number 12(2018) Page Start: 2468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗